Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.
Verified emails & LinkedIn for founders across this portfolio.
Zentalis is a pharmaceutical company focused on developing clinical therapeutics for cancer patients.
Abdera is an oncology company developing targeted alpha therapies (TATs) for patients with relapsed, refractory, and metastatic cancers.
Mantra Bio is the creator of REVEAL, an exosome engineering platform combining computational biology and lab automation.
Vector Biomed is a state-of-the-art custom vector design and GMP manufacturing company.
Locus Biosciences develops CRISPR-engineered precision antibacterial platform designed to revolutionize the treatment of bacterial disease.
Dock is a provider of a financial technology company that integrates card issuing and core banking services.
Revenova is a provider of CRM-powered transportation management systems (TMS) for 3PLs, Freight Brokers, Carriers and Shippers
Cognism is a B2B sales acceleration software company that provides a marketing and sales acceleration solution.
Arcaea's mission is to build a new foundation for the beauty industry through expressive biology.
Patina is reinventing primary care for adults 65+ so everyone gets the healthcare and aging experience they deserve.
Astarte Medical is clinical intelligence company providing digital solutions to support protocol-driven care across pediatric populations.
Boost Biomes develops microbial products to sustainably improve food production and shelf-life.
Algen Biotechnologies is a therapeutic discovery company that builds a platform to decode functional gene networks.
Developing safe and effective gene delivery platforms to unlock the therapeutic power of personalized, redoseable genetic medicine.
NextGen Jane is a data-driven women's health company.
1Health is a health platform that connects clinicians and patients to labs.
Valsoft specializes in the acquisition and growth of vertical-market software enterprises.
Xcell Biosciences is a next-generation development and manufacturing platform for enhanced cell therapy performance.
Humaneva is a healthacare research company that offers reliable clinical research data that empowers the medical community.
MyForest Foods grows meatless mycelium on vertical farms and supplies sustainable natural flagship products to consumers.
Human Immunology Biosciences is a biotechnology company that focuses on developing therapies for immune-mediated diseases.
Resilient Biotics utilizes big data analytics to design microbiome-based therapeutics and advanced screening methods.
A health tech company disrupting how those struggling to conceive access specialty fertility care through the best of science and tech.
A joint venture founded by Bayer and Ginkgo Bioworks developing probiotics for plants.
Viking Global Investors has invested in 56 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.
Viking Global Investors's top investment sectors include Biotechnology, Health Care, Medical, Therapeutics, Health Diagnostics. The firm invests across 56 different industry categories.
Among tracked funding rounds, Zentalis Pharmaceuticals received $235.5M in a Post-IPO Equity round. Viking Global Investors's total known invested capital is $3.0B.
Viking Global Investors's average investment size is $53.4M across its portfolio of 56 companies.
Recent Viking Global Investors portfolio additions include Zentalis Pharmaceuticals, Abdera Therapeutics, Mantra Bio, Vector Biomed, Locus Biosciences. These companies were founded in 2020 or later.